Ubs Group Ag Heart Beam, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Heart Beam, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 192,553 shares of BEAT stock, worth $300,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,553

Previous 199,267 3.37%

Holding current value

$300,382

Previous $249,000 27.31%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$0.94 - $1.69 $6,311 - $11,346	-6,714 Reduced 3.37%	192,553 $317,000
Q2 2025 Aug 14, 2025	SELL	$1.25 - $2.0 $4,712 - $7,540	-3,770 Reduced 1.86%	199,267 $249,000
Q1 2025 May 13, 2025	BUY	$1.94 - $2.48 $83,487 - $106,726	43,035 Added 26.9%	203,037 $408,000
Q2 2024 Aug 13, 2024	SELL	$1.8 - $2.94 $2,903 - $4,742	-1,613 Reduced 1.0%	160,002 $411,000
Q1 2024 May 13, 2024	SELL	$1.39 - $2.41 $22,376 - $38,796	-16,098 Reduced 9.06%	161,615 $352,000

Q4 2023 Feb 09, 2024	BUY	$1.13 - $2.5 $20,013 - $44,277	17,711 Added 11.07%	177,713 $417,000
Q3 2023 Nov 09, 2023	SELL	$1.93 - $3.26 $2,545 - $4,299	-1,319 Reduced 0.82%	160,002 $344,000
Q2 2023 Aug 11, 2023	BUY	$1.83 - $2.95 $290,194 - $467,799	158,576 Added 5776.9%	161,321 $388,000
Q1 2023 May 12, 2023	BUY	$2.08 - $4.6 $5,709 - $12,626	2,745 New	2,745 $6,000
Q3 2022 Nov 10, 2022	BUY	$1.18 - $4.18 $580 - $2,056	492 New	492 $2,000
Q2 2022 Aug 10, 2022	SELL	$1.24 - $1.96 $783 - $1,238	-632 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.59 - $3.67 $6,533 - $15,080	-4,109 Reduced 86.67%	632 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.93 - $4.69 $13,891 - $22,235	4,741 New	4,741 $15,000

Others Institutions Holding BEAT

# of Institutions

Shares Held

3.31M

Call Options Held

Put Options Held

View Full List

About HeartBeam, Inc.

Ticker BEAT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 8,000,870
Market Cap $12.5M
Description
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a ...

More about BEAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account